Lesley Ann Calhoun - 08 Jun 2022 Form 4 Insider Report for Tango Therapeutics, Inc. (TNGX)

Role
Director
Signature
/s/ Douglas Barry, as attorney-in-fact
Issuer symbol
TNGX
Transactions as of
08 Jun 2022
Transactions value $
$0
Form type
4
Filing time
28 Jun 2022, 16:28:24 UTC
Previous filing
08 Feb 2022
Next filing
11 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNGX Stock Option (Right to Buy) Award $0 +40,000 $0 40,000 08 Jun 2022 Common Stock 40,000 $5.9 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year from June 8, 2022, subject to the Reporting Person's continuous service on the board of directors as of each such vesting date.